1. Home
  2. DSP vs NNNN Comparison

DSP vs NNNN Comparison

Compare DSP & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viant Technology Inc.

DSP

Viant Technology Inc.

SELL

Current Price

$13.17

Market Cap

279.6M

Sector

Technology

ML Signal

SELL

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

BUY

Current Price

$4.49

Market Cap

270.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
DSP
NNNN
Founded
1999
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
279.6M
270.4M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
DSP
NNNN
Price
$13.17
$4.49
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
★ $19.50
N/A
AVG Volume (30 Days)
★ 621.6K
151.2K
Earning Date
11-09-2026
10-23-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 157.14
N/A
EPS
N/A
★ N/A
Revenue
★ $344,201,000.00
N/A
Revenue This Year
$28.58
N/A
Revenue Next Year
$20.44
N/A
P/E Ratio
★ N/A
$446.57
Revenue Growth
★ 19.00
N/A
52 Week Low
$8.16
$4.16
52 Week High
$14.80
$44.73

Technical Indicators

Market Signals
Indicator
DSP
NNNN
Relative Strength Index (RSI) 56.09 29.31
Support Level $9.55 N/A
Resistance Level $13.42 $6.95
Average True Range (ATR) 0.60 0.57
MACD 0.11 -0.03
Stochastic Oscillator 76.30 10.55

Price Performance

Historical Comparison
DSP
NNNN

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising technology company engaged in providing a cloud-based demand-side platform (DSP) for programmatic advertising. The company enables marketers and advertising agencies to plan, buy, and measure digital advertising campaigns across multiple channels, including connected TV, streaming audio, mobile, desktop, and digital out-of-home. Its platform leverages data integrations and proprietary identity solutions to deliver targeted advertising, audience insights, and performance measurement.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: